BVS
BVS
NASDAQ · Health Care

Bioventus Inc - A

$8.51
+0.30 (+3.65%)
As of Feb 8, 1:47 PM ET ·
Income Statement
FY 2026 FY 2025 FY 2025 FY 2024 FY 2023
Revenue 735.06M 668.36M 229.09M 241.82M 197.18M
Net Income -43,003,765 -35,191,297 25.80M 36.10M 22.67M
EPS
Profit Margin -5.9% -5.6% 11.3% 14.9% 11.5%
Rev Growth +10.0% +10.0% +13.8% -4.8% -2.4%
Balance Sheet
FY 2026 FY 2025 FY 2025 FY 2024 FY 2023
Total Debt 246.69M 246.69M 311.19M 254.88M 304.50M
Total Equity 105.47M 105.47M 289.03M 321.56M 308.93M
D/E Ratio 2.34 2.34 1.08 0.79 0.99
Cash Flow
FY 2026 FY 2025 FY 2025 FY 2024 FY 2023
EBITDA -5,114,766 -4,418,101 54.55M 52.99M 46.00M
Free Cash Flow 17.18M 25.01M 12.86M